Search the web
Welcome, Guest
[Sign Out, My Account]

Tuesday, August 4 2015 8:04pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery
More On This Industry
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
Industry Market Summary
Drug Delivery
Composite Value: 1025.6
Today's Change: -3.34%
S&P 500: -0.22%
chart for
[Drug Delivery (^YHOh786)]
Drug Delivery News
Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress
Tue 8:00 am ET (PR Newswire)
NEW YORK, Aug. 4, 2015 /PRNewswire/ -- Delcath Systems, Inc. (DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that two abstracts summarizing data from studies in Europe and the U.K. of treatment with the Delcath Hepatic CHEMOSAT® Delivery System (CHEMOSAT) will be presented at the upcoming European Association of Dermato Oncology (EADO) annual congress, which will be held in Marseille, France, October 28-31, 2015. Liver Directed Treatment Of Metastatic Uveal Melanoma By Chemosaturation Via Percutaneous Hepatic Perfusion – A Single Centre Experience, a study conducted at Southampton University in the United Kingdom. Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers.
Acura Pharmaceuticals Announces Second Quarter 2015 Financial Results - (Marketwire)
Alkermes reports 2Q loss - (AP)
More News on Drug Delivery: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
WALGREENS BOOTS [W8A.DE] -0.01% $95.3 B
Valeant Pharmaceuticals Interna [VRX] +1.08% $86.3 B
CLINIGEN GRP [CLIN.L] -0.18% $56.7 B
FRAGUA-B [FRAGUAB.MX] 0.00% $24.5 B
Alkermes plc [ALKS] -0.11% $10.1 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
08/12/15 BPHA3.SA Brasil Pharma SA Q2 2015 Earnings Release
10/29/15 RADL3.SA Raia Drogasil SA Q3 2015 Earnings Release
11/11/15 BPHA3.SA Brasil Pharma SA Q3 2015 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
08/03/15 ACUR Acura Pharmaceuticals, Inc. downside earnings surprise (-150.00%)
07/30/15 ALKS Alkermes plc upside earnings surprise (+10.00%)
07/30/15 FLML Flamel Technologies S.A. downside earnings surprise (-207.50%)
More Recent Events...
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:279B
Price / Earnings:172.8
Price / Book:-11.6
Net Profit Margin (mrq):7.8%
Price To Free Cash Flow (mrq):46.8
Return on Equity:7.4%
Total Debt / Equity:148.3
Dividend Yield:0.1%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
Unusually Active Boards
Board Variance

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?